May 14, 2019 / 06:20PM GMT
Kevin Mark Fischbeck - BofA Merrill Lynch, Research Division - MD in Equity Research
All right. I want to thank everyone for joining us today. It's my pleasure to introduce MEDNAX. MEDNAX is one of the largest physician staffing companies in the country with a primary focus on anesthesiology, neonatal and radiology.
Presenting today, we have Roger Medel, who is the CEO; Stephen Farber, who is the CFO; and Charlie Lynch, who is VP of Strategy and IR. They were nice enough or foolish enough to go right into Q&A. So by all means, I encourage anyone in the audience to ask whatever questions they might have, but maybe I'll kick it off.
Questions and Answers:
Kevin Mark Fischbeck - BofA Merrill Lynch, Research Division - MD in Equity ResearchI guess we'd love to kind of hear your thoughts about what the long-term kind of EBITDA growth organically in this business is? We've seen periods of low single-digit EBITDA growth, but then 2017, things kind of took a pretty significant turn to the negative, you've kind of reacted to that. But where are we